RHHBY - Roche Holding Ltd ADR - Stock Forecast

Drug Manufacturers - General - Industry

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RHHBY is currently covered by 1 analysts with an average price target of $40.7. This is a potential upside of $0.4 (0.99%) from yesterday's end of day stock price of $40.3.

Roche Holding Ltd ADR's activity chart (see below) currently has 5 price targets and 11 ratings on display. The stock rating distribution of RHHBY is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 82.89 days.

Highest price target for RHHBY is $34, Lowest price target is $34, average price target is $40.

Most recent stock forecast was given by STEVE SCALA from TD COWEN on 12-Sep-2023.

Currently out of the existing stock ratings of RHHBY, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$40

$-0.3 (-0.74%)

$48

1 years 8 months 19 days ago
(12-Sep-2023)

2/4 (50%)

$5.83 (17.06%)

716

Buy

$46.12

$10.13 (28.15%)

3 years 5 months 9 days ago
(22-Dec-2021)

1/1 (100%)

$-2.25 (-4.65%)

30

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RHHBY (Roche Holding Ltd ADR) average time for price targets to be met?

On average it took 82.89 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on RHHBY (Roche Holding Ltd ADR) with a proven track record?

STEVE SCALA

Which analyst has the current lower performing score on RHHBY (Roche Holding Ltd ADR) with a proven track record?

TRUNG HUYNH

Which analyst has the most public recommendations on RHHBY (Roche Holding Ltd ADR)?

Steve Scala works at KEYBANK and has 7 price targets and 5 ratings on RHHBY

Which analyst is the currently most bullish on RHHBY (Roche Holding Ltd ADR)?

Andrew Baum with highest potential upside - $10.13

Which analyst is the currently most reserved on RHHBY (Roche Holding Ltd ADR)?

Steve Scala with lowest potential downside - -$0.3

Roche Holding Ltd ADR in the News

Zealand Pharma AS (ZLDPF) Q1 2025 Earnings Call Highlights: Strategic Collaborations and ...

Revenue: DKK8 million for Q1 2025, primarily from the license and development agreement for Zegalogue with Novo Nordisk. Research and Development Expenses: DKK290 million, driven by the development of petrelintide and related trials. Sales and Marketing Expenses: DKK37 million, mainly for pre-commercial activities related to rare disease assets. General and Administrative Expenses: DKK65 million, reflecting...

Roche Holding AG (RHHBY) is a Great Momentum Stock: Should You Buy?

Momentum investing revolves around the idea of following a stock’s recent trend in either direction. In the ‘long’ context, investors will be essentially be “buying high, but hoping to sell even higher.” With this methodology, taking advantage of trends in a stock’s price is key; once a stock establishes a course, it is more than...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?